ArticleMolecular oncology2013

Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib.

Anjali Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.